It’s becoming a familiar refrain whenever MRI developer Fonar reports financial results: sales are up, but the revenue is coming from growth in healthcare services, not scanner sales. Last month was no exception, with the Melville, NY, company
Its becoming a familiar refrain whenever MRI developer Fonar reports financial results: sales are up, but the revenue is coming from growth in healthcare services, not scanner sales. Last month was no exception, with the Melville, NY, company reporting a 34% increase in second-quarter revenues at the same time that its scanner business remained in the doldrums.
For the period (end-December), Fonar reported sales of $9.1 million, compared with revenues of $6.8 million in the same period of 1998. The companys net loss for the quarter was $2.5 million, compared with a net loss of $2.1 million in the second quarter of fiscal 1998.
Health Management Corporation of America, Fonars physician practice management subsidiary, was the engine behind the companys revenue growth. Meanwhile, sales of Fonars Quad products amounted to only $602,000 for the quarter, compared with $1 million in the same period a year ago. Fonar believes that its new scanners, such as Open Sky MRI and Stand-Up MRI, will lead to sales growth when they begin shipping.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.